Molecular Pathways Controlling Platelet and Megakaryocyte Activity

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 31 May 2026 | Viewed by 59

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medicine, University of California, San Diego, CA, USA
Interests: platelets; stem cells; signaling; metabolism; hemodynamic stress

E-Mail Website
Guest Editor
Department of Medicine, Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School 75 Francis St., Boston, MA 02115, USA
Interests: platelet signaling; cancer biology

Special Issue Information

Dear Colleagues, 

Platelets are anucleate cell fragments derived from megakaryocytes (MKs) that reside primarily in the bone marrow but may also localize to the lungs. The early recognition of platelets as essential mediators of effective hemostasis and pathological thrombosis has fueled extensive research detailing multiple regulatory pathways that control platelet activation. Recent studies have further expanded the role of platelets as immune cells and contributors to the development and pathology of multiple organs. However, there is an ongoing search for novel molecules or a new understanding of established platelet players that determine specificity and distinguish these functions despite largely overlapping signaling pathways. MKs, besides producing platelets, act as critical components of the bone marrow niche and contribute to immune function. Ongoing research is focused on understanding the heterogeneity and spatial functions of MKs, as well as their potential roles in development and aging. 

In this Special Issue, we welcome original research and review articles that explore mechanisms of control of megakaryocyte and platelet function: (1) What are the molecular underpinnings that differentiate hemostatic and thrombotic pathways and potential mechanisms for their control? (2) Differentiation of iPSCs or hematopoietic stem cells into MKs and platelets, as well as gene editing, can be carried out effectively at a sufficient scale to permit in vitro investigations. How can these ex vivo platforms be further optimized to achieve an expanded yield? How can these technologies be applied to study the role of MKs in the regulation of hematopoietic niches, immune function, or aging? (3) Are there novel approaches to identifying and validating molecules of interest? Can high-throughput analysis protocols incorporating Omics studies, signaling pathway databases, molecular sequence-to-protein structure prediction algorithms, and AI be effective tools to streamline analysis? What are new options for more precise validation of identified targets? (4) What is the significance of metabolomics, including mitochondrial dynamics, to platelet and megakaryocyte function, and how could these be harnessed? This Special Issue aims to further our capabilities to selectively target specific functions of platelets and MKs.

Dr. Ana Kasirer-Friede
Dr. Deepa Gautam 
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • platelet
  • megakaryocyte
  • signaling
  • omics
  • immune

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop